Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
Clinical trial NCT03370120 · TERMINATED
Trial details
- NCT number
- NCT03370120
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2020-12-11
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.